Company · NXTC
NextCure, Inc.
Nasdaq's symbol directory lists NXTC on Nasdaq as “NextCure, Inc. - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 8 occasions ($1.8M); insiders sold on 1 occasion ($185K); 6 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- ADAR1 Capital Management, LLC bought $1.8M
- Simcere Zaiming, Inc. sold $185K
Every trade (9)
- BUYADAR1 Capital Management, LLC bought $18K
- BUYADAR1 Capital Management, LLC bought $8K
- BUYADAR1 Capital Management, LLC bought $27K
- SELLSimcere Zaiming, Inc. sold $185K
- BUYADAR1 Capital Management, LLC bought $179K
- BUYADAR1 Capital Management, LLC bought $1.4M
- BUYADAR1 Capital Management, LLC bought $17K
- BUYADAR1 Capital Management, LLC bought $32K
- BUYADAR1 Capital Management, LLC bought $39K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- JP Sailing Capital Ltd 9.9%
- ADAR1 Capital Management, LLC 15.8%
- Ikarian Capital, LLC 9.99%
- Squadron Capital Management LLC 1.6%
- Affinity Asset Advisors, LLC 6.4%
- Adage Capital Management, L.P. 7.67%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Departure or appointment of directors or officers Oct 30, 2026
- Other events Sep 25, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.